Diacomit® (stiripentol) – New orphan drug approval
August 20, 2018 - The FDA approved Biocodex’s Diacomit (stiripentol) for the treatment of seizures associated with Dravet Syndrome (DS) in patients 2 years of age and older taking Onfi® (clobazam).
Download PDF
